Tyrosine kinase inhibitors, also known as TKIs, have revolutionized the care of advanced endometrial cancer. These agents seem to potentially offer improved and durable responses for patients facing endometrial cancer. Join our 'TKIs for Endometrial Cancer’ Patient Education series, in which we explore what they are, how they work, and how to maintain quality of life during TKI treatment.
Custom, evidence-based visual guides in 20+ languages, delivered through structured patient pathways — with zero IT disruption.
Book a Demo
